Can forteo be taken for longer than two years?

Can Forteo be used beyond the two-year limit?

The FDA approved Forteo for a maximum treatment period of two years because of concerns about a potential risk of osteosarcoma observed in rat studies. Patients who have already reached this limit have few safe alternatives left.

How does the black box warning affect decisions to extend treatment?

The black box warning highlights the osteosarcoma risk that appeared in preclinical data. Even after two years of daily injections, clinicians rarely recommend continuing Forteo because crossing the limit puts patients into an uncharted safety zone.

What happens to bone density gains once treatment stops at two years?

Bone gains made during two years of Forteo use tend to fade quickly once therapy ends. Patients often switch to an antiresorptive agent such as alendronate or denosumab to maintain the Aufbau achieved with teriparatide.

Can biosimilars or generic versions allow longer treatment?

No generic teriparatide or Forteo biosimilar has cleared regulatory hurdles to bypass the two-year restriction. Any new entrants would still fall under the same safety cap unless new clinical data prove otherwise.

Why are companies challenging this patent?

Eli Lilly holds composition-of-matter and use patents covering teriparatide, composition-of-matter patents are scheduled to expire in 2029.